Cargando…
Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients
Phage therapy is recognized as a promising alternative to antibiotics in treating pulmonary bacterial infections, however, its use has not been reported for treating secondary bacterial infections during virus pandemics such as coronavirus disease 2019 (COVID-19). We enrolled 4 patients hospitalized...
Autores principales: | Wu, Nannan, Dai, Jia, Guo, Mingquan, Li, Jianhui, Zhou, Xin, Li, Feng, Gao, Yuan, Qu, Hongping, Lu, Hongzhou, Jin, Jing, Li, Tao, Shi, Lei, Wu, Qingguo, Tan, Ruoming, Zhu, Mingli, Yang, Lan, Ling, Yun, Xing, Shunpeng, Zhang, Jianzhong, Yao, Bangxin, Le, Shuai, Gu, Jingmin, Qin, Jinhong, Li, Jie, Cheng, Mengjun, Tan, Demeng, Li, Linlin, Zhang, Yiyuan, Zhu, Zhaoqin, Cai, Jinfeng, Song, Zhigang, Guo, Xiaokui, Chen, Li-Kuang, Zhu, Tongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032346/ https://www.ncbi.nlm.nih.gov/pubmed/33703996 http://dx.doi.org/10.1080/22221751.2021.1902754 |
Ejemplares similares
-
Characterization of Klebsiella pneumoniae ST11 Isolates and Their Interactions with Lytic Phages
por: Tan, Demeng, et al.
Publicado: (2019) -
A Frameshift Mutation in wcaJ Associated with Phage Resistance in Klebsiella pneumoniae
por: Tan, Demeng, et al.
Publicado: (2020) -
Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae
por: Bao, Juan, et al.
Publicado: (2020) -
Heterogeneous Klebsiella pneumoniae Co-infections Complicate Personalized Bacteriophage Therapy
por: Qin, Jinhong, et al.
Publicado: (2021) -
Guild-Level Microbiome Signature Associated with COVID-19 Severity and Prognosis
por: Guo, Mingquan, et al.
Publicado: (2023)